In Me We Trust: Public Health, Personalized Medicine, and the Common Good
By Donna Dickenson,
The Hedgehog Review
| 03. 12. 2014
Half of the population refuses to accept transfusions from public blood banks, trusting blood taken only from a family member or personally banked stocks. Is this just another example of Americans’ ruggedly individualistic distrust of all things public?
You might well think so, but the population in question is European. The finding comes from a Eurobarometer survey of European public opinion, evidence of increasingly transnational misgivings about what sociologist Richard Titmuss described in The Gift Relationship as the quintessential symbol of social solidarity: blood donation. In the wake of a series of scandals in France, Great Britain, and elsewhere in Europe, blood donation is becoming personalized and privatized on a global level.
Another symbol of our common humanity, the human genome, likewise faces the threat of biomedical privatization. The original vision of the human genome was communitarian. It was seen to be the common property of humanity. Article 1 of the UNESCO Universal Declaration on the Human Genome and Human Rights, issued in 1997, states that “the human genome underlines the fundamental unity of all members of the human family...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...